For example, discovery that the Von Hippel-Lindau syndrome (VHL), a disorder characterised by the formation of tumours and cysts, is caused by a single mutation in the VHL protein which perturbes binding to the hypoxia-inducible factor has led to the manufacture of novel cancer drugs[1-3]. The gene discussed is VHL; the disease is neoplasm.